Home
Drug Development
Novartis and University of Oxford to establish AI based Drug Development Alliance

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic Steatohepatitis

FDA grants fast track designation to ImmusanTs vaccine for celiac disease

Chinas National Medical Products Administration Approves Harvoni for Treatment of Chronic Hepatitis C Virus Genotype

Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

EMA Accepts Extension Marketing Authorisation Application for Review of Celltrions Remsima SC the subcutaneous version of Remsima
Manufacturing
Supply Chain
Facilities
Health & Nutrition
Events
Contact Us

No Result

View All Result

No Result

View All Result

No Result

View All Result

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

by Content Team 11th January 2019

Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®

by Content Team 29th August 2018

Drug Development

Daiichi Sankyo Launches NaruveinⓇ Injection for Cancer Pain Treatment in Japan

by Content Team 24th May 2018

Clinical Trials

Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association

by Content Team 21st May 2018

Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

by Content Team 22nd March 2018

Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market

by Content Team 13th February 2018

Clinical Trials

Chinese researchers report first lung stem cell transplantation clinical trial

by Content Team 13th February 2018

Drug Development

Using injectable self-assembled nanomaterials for sustained delivery of drugs Drug

by Content Team 13th February 2018

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

Latest News

Novartis and University of Oxford to establish AI based Drug Development Alliance

Drug Development

Novartis and University of Oxford to establish AI based Drug Development Alliance

by Content Team

22nd January 2019

Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) ...

Clinical Trials

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Drug Development

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic Steatohepatitis

7th January 2019

Drug Development

FDA grants fast track designation to ImmusanTs vaccine for celiac disease

7th January 2019

Chinas National Medical Products Administration Approves Harvoni for Treatment of Chronic Hepatitis C Virus Genotype

7th January 2019

Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

4th January 2019

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

4th January 2019

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

6th December 2018

Markets & Financial Moves

Bristol-Myers Squibb to acquire Celgene in $74bn deal

Bristol-Myers Squibb to acquire Celgene in $74bn deal

by Content Team

4th January 2019

Bristol-Myers Squibb Company and Celgene Corporation announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb...

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

30th November 2018

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline

19th September 2018

Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins

17th August 2018

Herbalife Nutrition Announces the Adjusted Price Range of Its Dutch Auction Tender Offer for Common Shares Following Stock-Split

Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018

Alexion Reports First Quarter 2018 Results And Positive Topline Data From ALXN1210 Phase 3 PNH Switch Study

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

22nd March 2018

Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance

White Papers

Most Read

TrakCel and Quick partner to provide Digital Supply Chain IT solution for Cell and Gene Therapies

TrakCel and Quick partner to provide Digital Supply Chain IT solution for Cell and Gene Therapies

22nd January 2019

Novartis and University of Oxford to establish AI based Drug Development Alliance

Drug Development

Novartis and University of Oxford to establish AI based Drug Development Alliance

22nd January 2019

Most Popular

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Almac Group Extends Personalized Cancer Vaccine Production Facilities

Almac Group Extends Personalized Cancer Vaccine Production Facilities

22nd January 2019

Press Statements

Packaging & Logistics

Novartis and University of Oxford to establish AI based Drug Development Alliance

Drug Development

Novartis and University of Oxford to establish AI based Drug Development Alliance

22nd January 2019

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

Clinical Trials

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Almac Group Extends Personalized Cancer Vaccine Production Facilities

Facilities & Operation

Almac Group Extends Personalized Cancer Vaccine Production Facilities

22nd January 2019

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic Steatohepatitis

Drug Development

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic Steatohepatitis

7th January 2019

FDA grants fast track designation to ImmusanTs vaccine for celiac disease

Drug Development

FDA grants fast track designation to ImmusanTs vaccine for celiac disease

7th January 2019

Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

Drug Development

Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

4th January 2019

Bristol-Myers Squibb to acquire Celgene in $74bn deal

Bristol-Myers Squibb to acquire Celgene in $74bn deal

4th January 2019

Canadian companies complete handover of drugs rights

Canadian companies complete handover of drugs rights

4th January 2019

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

4th January 2019

Video Channel

Currently Playing

SAS Drug Development for Small/Midsize Pharmaceutical & Biotech

SAS Drug Development for Small/Midsize Pharmaceutical & Biotech

packaging automation for pharma industry

Drug Development

Research & Development

Press Statements

SIRIO Pharma opens multimillion gummy production plant at new high-tech nutraceutical facility in Ma’anshan, China

by Content Team

12th November 2018

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

Drug Development

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

by Content Team

13th October 2018

Press Statements

New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute

by Content Team

12th September 2018

Clinical Trials

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

6th December 2018

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

5th December 2018

AMAL Therapeutics raises CHF 33.2 Million Series B Round

AMAL Therapeutics raises CHF 33.2 Million Series B Round

30th November 2018

AMAL Therapeutics raises CHF 33.2 Million Series B Round

13th November 2018

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

12th November 2018

Regulatory Approvals

Chinas National Medical Products Administration Approves Harvoni for Treatment of Chronic Hepatitis C Virus Genotype

Chinas National Medical Products Administration Approves Harvoni for Treatment of Chronic Hepatitis C Virus Genotype

7th January 2019

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

4th January 2019

Shire Receives European Approval for TAKHZYRO (lanadelumab) subcutaneous injection for the Preventive Treatment of Hereditary Angioedema

Shire Receives European Approval for TAKHZYRO (lanadelumab) subcutaneous injection for the Preventive Treatment of Hereditary Angioedema

3rd December 2018

European Commission Approves Mercks DELSTRIGO

30th November 2018

Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo

30th November 2018

FDA Approves First Drug Using the Recombinant Factor C Assay for Endotoxin Testing

12th November 2018

European Commission has granted Marketing Authorization for Vertex’s SYMKEVI

1st November 2018

Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza

25th October 2018

EC approves new easy-to-use, once-weekly Bydureon BCise device for patients with type-2 diabetes

7th September 2018

Facilities

Almac Group Extends Personalized Cancer Vaccine Production Facilities

Almac Group Extends Personalized Cancer Vaccine Production Facilities

22nd January 2019

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

Teva Completes Amendment to Credit Facilities

8th February 2018

iMedrix Announces General Availability of KardioScreen, a CE certified, Connected ECG Device for Universal Use

17th January 2018

Manufacturing

TrakCel and Quick partner to provide Digital Supply Chain IT solution for Cell and Gene Therapies

TrakCel and Quick partner to provide Digital Supply Chain IT solution for Cell and Gene Therapies

22nd January 2019

Novartis and University of Oxford to establish AI based Drug Development Alliance

Novartis and University of Oxford to establish AI based Drug Development Alliance

22nd January 2019

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Almac Group Extends Personalized Cancer Vaccine Production Facilities

Almac Group Extends Personalized Cancer Vaccine Production Facilities

22nd January 2019

Events and Exhibitions

Health & Nutrition

GE Healthcare to open biotechnology manufacturing center in UK

Health & Nutrition

GE Healthcare to open biotechnology manufacturing center in UK

by Content Team

3rd December 2018

GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in...

Nestle China accelerates innovation

Nestle China accelerates innovation

13th November 2018

GE increases cell culture media production capacity by tenfold

DSM invests to increase global Dyneema® production capacity

Natural History of Diabetes

9th February 2018

More News

Canadian companies complete handover of drugs rights

by Content Team

4th January 2019

Canadian companies complete handover of drugs rights

Nuvo Pharmaceuticals has acquired the rights covering more than 20 drugs from fellow Canadian company Aralez Pharmaceuticals. With the deal,...

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

by Content Team

4th January 2019

FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

Roche announced that the US FDA approved Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy), for the initial (first-line)...

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals

by Content Team

4th January 2019

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals

British pharmaceutical company Mereo BioPharma Group has announced a proposal to merge with US-based drugmaker OncoMed Pharmaceuticals. The integrated business...

IQVIAs OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency

by Content Team

12th December 2018

IQVIAs OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency

IQVIA announced that Napo Pharmaceuticals, Inc. (Napo), a wholly-owned subsidiary of Jaguar Health, Inc., has selected Orchestrated Customer Engagement (OCE),...

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

by Content Team

6th December 2018

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

Bluebird bio, Inc. and Celgene Corporation announced initial data from the ongoing Phase 1 clinical study of bb21217 (CRB-402), an...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

Resources

System

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result

View All Result

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.